<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03451994</url>
  </required_header>
  <id_info>
    <org_study_id>20111001005MEBO</org_study_id>
    <nct_id>NCT03451994</nct_id>
  </id_info>
  <brief_title>Exploratory Study of Volatile Organic Compounds in Alveolar Breath</brief_title>
  <acronym>VOCs</acronym>
  <official_title>Retrospective Analysis of Volatile Organic Compounds in Alveolar Breath as Biomarkers of Idiopathic Malodor</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Mebo Research, Inc.</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Menssana Research, Inc.</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
    <collaborator>
      <agency>Aurametrix</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Mebo Research, Inc.</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this secondary analysis is to identify breath signatures associated with
      idiopathic malodor conditions.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Individuals with metabolic disorders may sporadically produce malodors despite good hygiene.
      Analysis of volatile organic compounds (VOCs) helps to gain insights into medical conditions
      arising due to metabolic dysfunction as different metabolic pathways emit and or consume
      various VOCs. These VOCs can be detected via the exhaled breath collected and analyzed with a
      portable breath collection apparatus. VOC profiles will be compared with self-reported
      symptoms and other observations of participating subjects.
    </textblock>
  </detailed_description>
  <overall_status>Active, not recruiting</overall_status>
  <start_date type="Actual">October 1, 2011</start_date>
  <completion_date type="Anticipated">December 1, 2018</completion_date>
  <primary_completion_date type="Actual">December 31, 2013</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>VOCs detected</measure>
    <time_frame>2 years</time_frame>
    <description>Expired air sample drawn principally from alveolar breath is analyzed by gas chromatography-mass spectrometry. Chromatograms are searched against the NIST library. The response for each analyte is normalized by using internal standards containing 1‐bromo‐4‐fluoro-benzene.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Correlations between breath biomarkers and self-reported observations (questionnaires)</measure>
    <time_frame>1 year</time_frame>
    <description>VOC profiles will be compared with self-reported symptoms, observed exposures and other observations of participating subjects. Volatile organic compounds differentiating the disease activity will be identified.</description>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Actual">15</enrollment>
  <condition>Nutritional and Metabolic Diseases</condition>
  <arm_group>
    <arm_group_label>Body odor</arm_group_label>
    <description>individuals self-reporting idiopathic body odor with or without bad breath</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Breath odor</arm_group_label>
    <description>individuals self-reporting idiopathic bad breath but no body odor</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Breath test</intervention_name>
    <description>Breath samples taken from all participants, analyzed with gas chromatography mass spectrometry (GC/MS), no treatment given.</description>
    <arm_group_label>Body odor</arm_group_label>
    <arm_group_label>Breath odor</arm_group_label>
    <other_name>Exhaled breath metabolomics</other_name>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Individuals self-reporting idiopathic malodor production as a consequence of a systemic
        disorder
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  good general health

          -  willing and able to travel to one of the participating sites

        Exclusion Criteria:

          -  medical conditions that, in the opinion of the investigator, would prevent
             participation

          -  elect not to participate in the study
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Irene Gabashvili, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>MeBO Research</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>MeBO Research</name>
      <address>
        <city>Miami</city>
        <state>Florida</state>
        <zip>33175</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>MeBO Research LTD</name>
      <address>
        <city>London</city>
        <state>England</state>
        <zip>W10 5LE</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United Kingdom</country>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Phillips M. Method for the collection and assay of volatile organic compounds in breath. Anal Biochem. 1997 May 1;247(2):272-8.</citation>
    <PMID>9177688</PMID>
  </reference>
  <verification_date>February 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 18, 2018</study_first_submitted>
  <study_first_submitted_qc>February 25, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">March 2, 2018</study_first_posted>
  <last_update_submitted>February 25, 2018</last_update_submitted>
  <last_update_submitted_qc>February 25, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">March 2, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Metabolic Diseases</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

